StreetInsider.com News Articles

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

DUBLIN--(BUSINESS WIRE)-- Alkermes plc (Nasdaq: ALKS) today announced that it will begin accepting applications for its inaugural Alkermes Pathways APN Research Awards™ program on Monday, March 16, 2026. This competitive grant program is designed to support research conducted by advanced practice nurses (APN), specifically licensed psychiatric-mental health nurse practitioners who are actively

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

Thu, 12 Mar 2026 07:00:00 -0400

— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project —

— Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings —

— Application Period to Run From March 16, 2026 Through June 1, 2026 —

Alkermes to Present at the Stifel 2026 Virtual CNS Forum

Tue, 10 Mar 2026 16:00:00 -0400

DUBLIN--(BUSINESS WIRE)-- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026 at 8:30 a.m. ET (12:30 p.m. GMT). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc
Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of

Alkermes to Present at the Stifel 2026 Virtual CNS Forum

Tue, 10 Mar 2026 16:00:00 -0400

Alkermes to Present at the Stifel 2026 Virtual CNS Forum

Tue, 10 Mar 2026 16:00:00 -0400

Alkermes to Present at the Stifel 2026 Virtual CNS Forum

Tue, 10 Mar 2026 16:00:00 -0400

Truist Securities Reiterates Buy Rating on Alkermes (ALKS): "remains one of our highest conviction BUY rated stocks"

Tue, 10 Mar 2026 08:24:43 -0400

Truist Securities analyst Joon Lee reiterated a Buy rating and $55.00 price target on Alkermes (NASDAQ: ALKS)

The analyst commented, "We hosted a lively dinner with mgmnt (Richard Pops, Blair Jackson and Sandra Coombs) in Miami where focus of the conversation revolved around forthcoming ORX750 data update (in ~next couple of weeks) and pricing of oveporexton given anticipated launch in 3Q26. Takeaway was that both of these events represent upsides for ALKS' alixorexton, based on current sentiment and buyside base case expectations. Orexin's therapeutic potential beyond sleep were also discussed. Net-net, ALKS remains one of our highest conviction BUY rated stocks

Form 4 Alkermes plc. For: Mar 02 Filed by: Reed Joshua

Wed, 04 Mar 2026 20:21:00 -0400

si-local-file:///var/storage/secattach/20260304/26113604.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Reed Joshua

Wed, 04 Mar 2026 20:21:00 -0400

si-local-file:///var/storage/secattach/20260304/26113604.html

Form 4 Alkermes plc. For: Mar 02 Filed by: POPS RICHARD F

Wed, 04 Mar 2026 20:20:00 -0400

si-local-file:///var/storage/secattach/20260304/26113602.html

Form 4 Alkermes plc. For: Mar 02 Filed by: POPS RICHARD F

Wed, 04 Mar 2026 20:20:00 -0400

si-local-file:///var/storage/secattach/20260304/26113602.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Parisi Samuel Joseph

Wed, 04 Mar 2026 20:19:00 -0400

si-local-file:///var/storage/secattach/20260304/26113597.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Parisi Samuel Joseph

Wed, 04 Mar 2026 20:19:00 -0400

si-local-file:///var/storage/secattach/20260304/26113597.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Nichols Christian Todd

Wed, 04 Mar 2026 20:18:00 -0400

si-local-file:///var/storage/secattach/20260304/26113592.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Nichols Christian Todd

Wed, 04 Mar 2026 20:18:00 -0400

si-local-file:///var/storage/secattach/20260304/26113592.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Jackson Blair Curtis

Wed, 04 Mar 2026 20:17:00 -0400

si-local-file:///var/storage/secattach/20260304/26113590.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Jackson Blair Curtis

Wed, 04 Mar 2026 20:17:00 -0400

si-local-file:///var/storage/secattach/20260304/26113590.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Gaffin David Joseph

Wed, 04 Mar 2026 20:16:00 -0400

si-local-file:///var/storage/secattach/20260304/26113583.html

Form 4 Alkermes plc. For: Mar 02 Filed by: Gaffin David Joseph

Wed, 04 Mar 2026 20:16:00 -0400

si-local-file:///var/storage/secattach/20260304/26113583.html